Evidence map›Paper›PMID 41268068›Full record

ArticleHuman reproduction open2025

Spermatocyte injection into meiotic oocytes rescues diplotene, but not pachytene, arrest in azoospermic mutant mice.

Narumi Ogonuki, Toshiaki Hino, Yasuhiro Fujiwara, Yuki Osawa, Seiya Mizuno, Fumihiro Sugiyama, Tetsuo Kunieda, Junko Otsuki, Seiya Oura, Tamio Furuse and 6 more

Abstract read
In one paragraph

Article in Human reproduction open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Narumi OgonukiIntegrative Developmental Engineering Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
Toshiaki HinoDepartment of Biological Sciences, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.ORCID https://orcid.org/0009-0007-6521-3540
Yasuhiro FujiwaraLaboratory of Pathology and Development, Institute for Quantitative Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Yuki OsawaMaster's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Seiya MizunoLaboratory Animal Resource Center and Trans-border Medical Research Center, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Fumihiro SugiyamaLaboratory Animal Resource Center and Trans-border Medical Research Center, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Tetsuo KuniedaGraduate School of Environmental Life, Natural Science and Technology, Okayama University, Okayama, Okayama, Japan.
Junko OtsukiHanabusa Women's Clinic, Kobe, Hyogo, Japan.ORCID https://orcid.org/0000-0002-8183-8651
Seiya OuraDepartment of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.ORCID https://orcid.org/0000-0002-7606-732X
Tamio FuruseMouse Phenomics Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
Yuki OkadaLaboratory of Pathology and Development, Institute for Quantitative Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Masaru TamuraMouse Phenomics Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
Elena de la Casa-EsperonBiomedicine Institute (IB) and Faculty of Pharmacy, University of Castilla-La Mancha and IDISCAM, Albacete, Spain.ORCID https://orcid.org/0000-0001-6821-7896
Masahito IkawaDepartment of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.ORCID https://orcid.org/0000-0001-9859-6217
Kimiko InoueIntegrative Developmental Engineering Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.ORCID https://orcid.org/0000-0001-7344-4786
Atsuo OguraIntegrative Developmental Engineering Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.ORCID https://orcid.org/0000-0003-0447-1988

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

study questionAt which arrest stage can spermatocytes be rescued by injection into meiotic oocytes? SUMMARY ANSWER: In mice, spermatocytes arrested at the diplotene stage, but not at the pachytene stage, can resume meiosis within immature oocytes and support full-term embryonic development. WHAT IS KNOWN ALREADY: In mice, at least some of the spermatocyte arrest mutations can be overcome by injecting spermatocytes into immature oocytes. STUDY DESIGN SIZE DURATION: The study was carried out from October 2019 to April 2025. Adult azoospermic mice (at 4-26 weeks of age) from nine strains carrying spermatocyte arrest mutations were used as spermatocyte donors. Adult B6D2F1 females at 9-12 weeks of age were used as oocyte donors for spermatocyte injection. Adult ICR strain pseudopregnant females at 9-12 weeks of age were used as recipients for embryo transfer experiments. PARTICIPANTS/MATERIALS SETTING

methodsThe most advanced stage of spermatocytes from each mutant strain was assessed by chromosome spread analysis. These most advanced spermatocytes of each strain were injected into metaphase I (MI) oocytes. About half a volume of the ooplasm had been removed from the recipient oocytes to ensure more stable chromosome behaviours during meiosis. The spermatocyte-injected oocytes were allowed to mature MAIN RESULTS AND THE ROLE OF CHANCE: Based on spermatocyte spread analysis, sperm mutants were categorized into three classes: Class 1, arrest at mid-diplotene or later stage; Class 2, arrest at early diplotene stage; and Class 3, arrest at pachytene stage. All four Class 1 mutants could resume normal meiosis following injection into MI oocytes, as evidenced by births of normal offspring. Similarly, one of two Class 2 mutants could be rescued, but the other could not. By contrast, three Class 3 mutants did not support embryo development to term because of complete implantation failure, indicating that reconstructed embryos carried severe chromosomal aberrations. LARGE-SCALE DATA: N/A. LIMITATIONS REASONS FOR CAUTION: The number of mutant strains examined was limited. Nevertheless, the findings were consistent: the more advanced the arrest stage of spermatocytes, the higher the likelihood of a successful rescue. WIDER IMPLICATIONS OF THE

findingsIn humans, a considerable proportion of spermatogenic arrest occurs at the primary spermatocyte stage. Spermatocyte injection might be an option to treat human male-factor infertility due to azoospermia in the future. However, numerous ethical and technical challenges remain to be addressed, and the reproductive physiological differences between mice and humans must be carefully taken into account. STUDY FUNDING/COMPETING INTERESTS: This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science to A.O. (grant number: JP19H05758), K.I. (grant number: 23H04956), M.I. (grant number: JP23K20043), and N.O. (grant number: 25H01372), and 2023 and 2025 grants of the University of Castilla-La Mancha for stays in foreign universities and research centres to E.C.-E. The authors declare that they have no conflicts of interest.

Indexed as

azoospermiafertilizationmeiosismousemutationoocytespermatocyte

Identifiers

PMID41268068
PMCPMC12628785

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.